Xarelto

The blood thinner Xarelto is linked to uncontrolled bleeding.

Approved in 2011, Xarelto is a new type of blood thinner manufactured by Bayer and marketed in the United States by Johnson & Johnson’s subsidiary, Janssen Pharmaceuticals. It is once-daily pill for atrial fibrillation, a condition that affects about 3 million people in the United States. Xarelto is prescribed to prevent blood clots that can obstruct the blood flow to vital organs.

Xarelto Side Effects

Side effects associated with Xarelto include:
  Intestinal Bleeding
  Brain Hemorrhaging
  Internal Bleeding
  Heart Attack
  Gastrointestinal Bleeding
  Blood Clots
  Stroke
  Death

When bleeding occurs near a major organ, blood flow to that organ is interrupted, causing it to lose some or all of its functionality. Pools of blood may form within the body that can cause other dangerous health risks, and because Xarelto prevents clotting, bleeding will continue until the drug is out of the system.

Xarelto is considered a high-risk prescription drug because it can cause excessive internal bleeding among other injuries in patients. While all blood thinners have the risk of internal bleeding, older drugs have emergency antidotes to prevent serious injury. Xarelto does not have an antidote.

The content on this web page is for informational purposes only.